
Evaluation of sitagliptin therapy on the levels of fibroblast growth factor-19 (FGF19) in patients with Type 2 diabetes
Author(s) -
Özen Öz Gül,
Soner Cander
Publication year - 2022
Publication title -
turkish journal of internal medicine (online)
Language(s) - English
Resource type - Journals
ISSN - 2687-4245
DOI - 10.46310/tjim.1070223
Subject(s) - sitagliptin , medicine , postprandial , body mass index , fgf19 , anthropometry , diabetes mellitus , type 2 diabetes , fgf21 , type 2 diabetes mellitus , gastroenterology , endocrinology , fibroblast growth factor , receptor